Erin Prater

Stay informed with Erin Prater’s coverage and analysis for Coins2Day.

Page 9 of 36

Zuranolone, trade name Zurzuvae—a steroid that works to rapidly repair dysregulated neuronal networks in the brain—was approved by the U.S. Food and Drug Administration on Friday for use in women with postpartum depression. It’s only the second drug approved for the condition, and the first in pill form.

Zuranolone, a breakthrough postpartum depression treatment, was just approved by the FDA. The fast-acting pill can improve symptoms in 3 days

By Editorial Team

Business people or businesspeople running from the virus as coronavirus or covid-19 with businessmen and businesswomen escaping from disease as a reopening or quarantine concept with 3D illustration elements.

Is the U.S. headed for another ‘tripledemic’ this fall? As COVID cases and hospitalizations rise, experts warn it could happen again

By Industry Analyst

Portrait of self-confident senior man with his granddaughter in a park

These 10 U.S. states are predicted to have the most people with Alzheimer’s disease. Here’s why

By Tech Reporter

Photo illustration of man's arm in suit lighting birthday candles on cake.

Americans could live an extra 19 years—if they pick the right employer

By Staff Writer

bottle of Kombucha variety probiotic drink on wooden table background.

Drinking kombucha may improve blood sugar levels. Here’s why

By Investment Desk

Rear view of young Asian woman grocery shopping for wines in a supermarket. She is standing in front of the liquor aisle and have no idea which wine to choose from

All of the buzz: A new breakthrough in liquor tech could be the key to avoiding hangovers altogether

By Financial Writer

Photo illustration of a golden genie lamp with glowing smoke coming out of the tip and DNA helixes floating within the smoke

Curious about your cancer risk, or if your child might develop learning disabilities? There’s a genetic test for that—but it may not be accurate

By News Correspondent

Artistic rendering of a crowded beach and coronaviruses on top of it

Has COVID-19 become a summer illness? Cases and hospitalizations are on the rise again

By Contributing Writer

Senior woman smelling flowers in garden

Those most at risk of developing Alzheimer’s may lose this sense before cognitive decline sets in, new research suggests

By Crypto Correspondent

runner, independent woman, muslim, proud, focused, fun-loving, challenging

Adopting these 8 healthy habits by middle age could add between 23 and 24 years to your life

By Staff Writer

This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication “Ozempic” (semaglutide) made by Danish pharmaceutical company “Novo Nordisk”. – On TikTok, the hashtag “#Ozempic” has reached more than 500 million views: this anti-diabetic medication is trending on the social network for its’ slimming properties, a phenomenon that is causing supply shortages and worrying doctors. (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images)

Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust

By Senior Editor

Man self isolating at home

COVID in your house? Isolating from sick family members may not do much good, according to a new study

By Research Team

Barbie dolls are seen at a toy shop in Krakow, Poland, on July 17. Barbie manufacturer Mattel is being accused of “stealth marketing” to children via a program that gives away free dolls to schools to promote social skills—a program some experts say could do more harm than good.

Barbie manufacturer Mattel criticized for giving free dolls to schools in bid to teach social skills: ‘Why should children be exposed to this type of stealth marketing?’

By Investment Desk

A sixty-five year old dentist doing oral care on an ethnic pregnant patient. He is wearing scrubs and surgical gloves as he meticulously cares for her teeth.

Not brushing or flossing regularly? You could be hurting your body’s ability to fight off Alzheimer’s disease. What you need to know

By Tech Reporter

Coins2Day Editor in Chief Alyson Shontell, right, speaks with Blueprint CEO Bryan Johnson on Wednesday at the magazine's Brainstorm Tech conference in Park City, Utah. This year Johnson conducted what he refers to as the "world's first multigenerational plasma exchange," involving his 17-year-old son and 70-year-old father.

Tech CEO defends using his 17-year-old son’s blood plasma in pursuit of youth, despite it not working

By News Correspondent

Web Analytics